Trade war will outlast Trump, warns Lazard

--  |   11/09/2019 Text size  Decrease  Increase   |  
email_fwd
<p><strong>Lex Hall: </strong>Hi, I'm Lex Hall for Morningstar. Welcome to another edition of "Ask the Expert." Today, I am joined by Ron Temple from Lazard Asset Management. He oversees US equities. We're going to talk about the global outlook and how investors should be positioning or repositioning for the turmoil ahead.</p> <p>Hi, Ron.&nbsp;</p> <p><strong>Ron Temple:</strong> Hi.</p> <p><strong>Hall: </strong>About 18 months ago, I was writing a piece about the trade war, the burgeoning trade war, and people were sort of shrugging their shoulders a bit and saying, "oh, we are not sure that it will have a particular effect on company earnings, and so on." And now, these days, it seems that every market report you read is based on the fluctuations in the trade war tensions. How do you react to that?</p> <p><strong>Temple:</strong> I think people have underestimated the trade war for the last few years pretty consistently and still today, even in spite of all this attention in recent weeks, months, are still underestimating the severity and the duration of the trade war between the US and China. Not to mention, by the way, we rarely talk about the potential trade war between the US. and Europe as it relates to auto and auto parts. If we focus on China, I do think it is a critically important thing to think about for investors over the years ahead. And I would highlight part of why I say people are underestimating and why I'm more negative on the long-term outlook on China is I think it's evolved from an economic dispute around trade deficits, intellectual property, market access, industrial policy, which you can negotiate, to increasingly be viewed in Washington DC on a bipartisan basis as a national security issue. And put simply, I think, in the US people used to think of China as an economic competitor, but increasingly people are thinking of it as a national security adversary.</p> <p>And so, with that in the backdrop, what has largely been a story so far of tariffs and a negotiation on economics, is becoming increasingly a story around restrictions on investments in US companies by Chinese companies, restrictions around the trade of technology products. And there's a view again in Washington that we need to curtail the flow of advanced technologies that in any way could be used for military application. So, I think this is likely to continue to deteriorate.</p> <p>To be very clear, I think we will have periods of time where the pressure rises on the US administration to try to get a deal or to make the markets think a deal is coming. And you might have bits of reprieves here. So, I tend to think of ebbs and flows with a structurally more negative trajectory for this relationship. And I think it will last well beyond Trump administration, whether it's a democrat or a republican replacing them, although the tenor of the conversation might change.</p> <p><strong>Hall: </strong>OK. You go to China a lot. What are people on the ground in China saying about the trade war?</p> <p><strong>Temple:</strong> I think over the last two years, there's been a range of reactions. I think, in the early days, the biggest issue in China was trying to figure out, A, with whom to negotiate, because in traditional times, you would negotiate with the US trade rep or someone from the Department of Commerce. And you might recall, in the early days when China was negotiating, they negotiated with Wilbur Ross, Secretary of Commerce, and with Steven Mnuchin. And then, they found that whatever they had negotiated really didn't hold water because the President didn't accept it. So, there was a question of, A, with whom should we speak? And then, B, if you think about any negotiation any of us ever have, you sit down at the table and you try to think beforehand, well, what is the other side of the table, what are they trying to accomplish? And it's been very difficult for the Chinese side to nail down exactly what the US wanted.</p> <p>So, again, you might recall in the early rounds, China's offer was to buy more American products, more soybeans, more natural gas. Because I think the view was, well, if we just buy more stuff, reduce the trade deficit, that will solve the problem. But as I mentioned before, since it's evolved, it's very tough. So, I think there's a real challenge of, A, can we really negotiate in good faith with the Trump administration; B, what exactly does the administration want; C, of the list of things they want, what's negotiable and what's nonnegotiable. So, for example, the idea that the US sees China as a military adversary potentially down the road and wants China to basically no longer have access to certain technology is really a nonnegotiable item for China. The idea that the US says the Made in China 2025 initiative is patently unfair, and that the industrial policies are uncompetitive or unfair to foreign competition. Asking China to change its economic system might be a nonnegotiable item if you're advising Xi Jinping. So, I think on that side, there's a real challenge of figuring out how you approach the negotiation and whether you can in good faith reach some kind of agreement.</p> <p><strong>Hall: </strong>OK. While you've got your sort of political strategist hat, kind of, half on, what do you think of the trade war in relation to the upcoming US election and Trump's position? How do you think it will change? China has less to lose arguably in this sense, because it's not running for an election. How do you see that playing out?</p> <p><strong>Temple:</strong> Well, let's take it from two sides. Let's take it from the US side and from the Chinese side. On the US side, it's really interesting in that &ndash; I mentioned before the national security view of China is somewhat bipartisan. It's not everyone, but I would generalize it as bipartisan. Interestingly, until the last couple of weeks, none of the Democratic candidates for president have really criticized Trump for what he's doing on China. The primary criticism has been that the approach to addressing the grievances has been counterproductive or unproductive. So, it's more that kind of criticism of means not ends.</p> <p>In the last couple of weeks that started to change. So, what you've seen is the economic anxiety has been increasing in the business community for over well over a year-and-a-half. It's starting to contaminate or infect the household sector. And we can come back to this later perhaps, but the core anchor to my optimism on the US economy has been a strong household sector, consumer confidence, wage growth, et cetera, that's starting to crack. And in particular, at the late part of August, we got a University of Michigan consumer confidence reading that was the &ndash; or maybe this early September &ndash; the biggest single month decline in confidence for consumers since 2012 during the Eurozone crisis, and one-third of the respondents volunteered the trade was driving their anxiety.</p> <p>In the same week, we got a Monmouth political survey. They got headlines because it said five democrats could be Trump. But what was more interesting to me, because I think that headline is really not terribly useful this early in a campaign, was that 37 per cent of voters said that the US economy is on the wrong track and is weakening; 31 per cent said it's on the right track. And that's the first time you've had a negative response since Trump got elected. So, I think if you're in the Trump administration, your anxiety level is increasing as you see a synchronised global industrial deceleration, business confidence going down and early signs that maybe that seeping into the consumer side. And the key for the playbook for Trump to win reelection is economic strength.</p> <p>Now, on the Chinese side, I think there's also an interesting thing, it's not just the United States that has to decide to reach an agreement. The Chinese have a calculus here. A, if you're Xi Jinping, it's nice not to have elections. Knowing that Donald Trump faces this issue, there should be a real conversation in Beijing about whether China should give the US a deal. So, I tend to try to put myself on both sides when I think about this. If I were advising Xi Jinping, it's actually a bit of a jump ball at this point of do I basically say, let's have the negotiations and keep stringing this along, let's see what happens to his poll ratings. Because this is a man who said within the last couple weeks, if I get reelected, you're going to have an even tougher time getting a deal. Well, then if you're Xi Jinping, and you actually hold some cards here, maybe you want to play the cards in a way that makes it less likely that Trump is the President in 2021. So, I think we should not neglect to think about the Chinese motivations and their leverage because I think China has quite a bit of leverage.</p>

Video Archive...

The WFH reality-check for REITs
28/05/2020  Working from home means upheaval for office landlords but shopping mall owners are enjoying the end of hibernation, says Morningstar's Brian Han.
An undervalued, wide-moat name in healthcare
27/05/2020  Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names.
5 investing mistakes to avoid
20/05/2020  Christine Benz discusses pitfalls investors encounter as they navigate volatility and recovery.
Ugly housing outlook won’t last
19/05/2020  Adelaide Brighton, Amcor and Bingo should ride out the housing construction slump with relative ease, says Morningstar’s Grant Slade. 
3 stocks set to clean up
18/05/2020  The biggest corporate hygiene company you never heard of; Dettol's parent company; and a lab supplier are tipped to benefit post-coronavirus.
Greencape's three top picks
13/05/2020  Property listings, software for financial planners and AI machine-learning: Jonathan Koh has scoured the globe for opportunities.
Where to hunt when guidance statements get torn up
12/05/2020  Greencape Capital entered the downturn with a cash reserve that has allowed it to snare some essential services companies at bargain prices, says Jonathan Koh.
Investing basics: the hardest decision in investing
08/05/2020  When and how should you get back into equity markets after panic selling?
Weighing up Australia’s banks
07/05/2020  Bad debts and expected capital raising from three of the big four cloud the outlook for Aussie banks, says Morningstar's Nathan Zaia.
Surprises from Berkshire's annual meeting
05/05/2020  Morningstar's Gregg Warren discusses the meeting's cautious tone, Berkshire's lack of buying during the downturn, and unloading the airlines.
Banks will see out corona crisis
04/05/2020  Loan defaults, shaky house prices and a dividend pause - it's ugly in the short term but Nathan Zaia has long-term faith in Australia's banks.
What the pandemic means for Berkshire Hathaway
30/04/2020  Gregg Warren shares his thoughts on its valuation and more.
Netflix steals the show but for how long?
29/04/2020  What happens when the lockdown ends? The streaming giant may need to get some serious growth in international markets to make up for investor expectations. 
Unique, but normal: riding out this market crisis
27/04/2020  The markets follow patterns. We discuss ways to find your way to the upside of the current environment.
3 defensive utility stocks
23/04/2020  These utility stocks aren't the cheapest but have solid balance sheets and decent yield potential.
What in the world happened to oil prices?
22/04/2020  Amid such a painful downturn and the ensuing demand shock, it's crucial to consider companies that are in sound financial health, says Dave Meats.
'An apocalyptic asset': owning gold
21/04/2020  Gold can be a useful insurance policy for investment portfolios, says Morningstar analyst Kenneth Lamont, but it's not perfect
Energy crisis will be short-lived
20/04/2020  Will energy majors bounce back from the coronavirus-induced turmoil? You bet they will, says Mark Taylor and here are the names to watch.
What role do bonds play in an era of ultralow yields?
16/04/2020  Investors are right to be questioning bonds' role in their portfolios, but they still serve a useful purpose for many.
US tech sector now decently undervalued
14/04/2020  We examine how this sector handled the market turmoil and what to expect
Will energy stocks rise from the ashes?
09/04/2020  Investors' current concerns are justified, but vast long-term opportunities remain in this significantly undervalued sector.
Corona crisis threatens big four dividends
08/04/2020  The short-term may be scary but the major banks' long-term outlook will withstand the shock, says Morningstar's Nathan Zaia.
What to expect as the virus continues
08/04/2020  Christine Benz and Karen Andersen discuss Morningstar's latest views on stopping the spread of the virus as well as the economic implications.
In volatile markets, it's OK to chicken out
03/04/2020  Christine Benz explains why now isn't the time for grand gestures with your investments; instead, take a light touch to them.
Avoiding all eggs in the same basket
02/04/2020  Get the full effect of diversification by considering the correlation of your assets with these tips from Morningstar's Director of Investment Research, Ian Tam
Coronavirus: stock up on quality companies
01/04/2020  Retail and energy companies rank among Morningstar's sector picks, despite seeing some of the sharpest falls since coronavirus hit.
Is this 2008 all over again?
31/03/2020  Eric Jacobson explains why the banking system is not at the centre of the corona crisis, and in fact, is well positioned to be a tool to help solve it.
The critical reason to stay invested
30/03/2020  Why it's important to stay invested to capture critical months for your portfolio, with Morningstar's director of investment research, Ian Tam
How to avoid dividend cuts
27/03/2020  A wave of companies are expected to cut their dividends amid the coronavirus crisis. Morningstar's Dan Lefkovitz explains how to spot a firm that could its pay out.
Healthcare stocks still defensive, says Morningstar
26/03/2020  Respiratory specialist Fisher & Paykel Healthcare is among stocks now enticingly priced as the coronavirus hits markets and the Aussie dollar.
Cheap or nasty? Seven, Nine and Telstra
24/03/2020  A stock that’s heavily sold down isn’t always a screaming buy, as proven by this comparison of debt and other fundamentals among these well-loved companies.
Mining stocks offer price opportunity, dividend threat
20/03/2020  OZ Minerals, South32 and Iluka are among miners dipping into buy territory amid the coronavirus selloff but dividends are at risk, says Morningstar’s Mat Hodge.
Market, economic implications amid latest virus news
20/03/2020  Karen Andersen and Preston Caldwell give us their latest perspectives on healthcare and energy.
'The long-term bounceback will be strong'
17/03/2020  The coronavirus fallout is hurting but there should be a treatment by year end and the rebound will be strong, says Morningstar director of equities Johannes Faul. 
Taking control in time of corona
17/03/2020  In this timely Morningstar panel discussion, but Christine Benz and Andrew Lill provide  concrete tips on how curb your losses and put your money to use.
The importance of staying invested in volatile times
16/03/2020  Don't flee the market in a panic, but rather embrace the turmoil as an investment opportunity—you'll be better off in the long run.
‘A modest sell-off, not a panic’: Douglass on coronavirus fallout
14/03/2020  The Magellan co-founder insists now is not the time to ditch stocks for cash nor to buy bargains, and global businesses won’t turn their backs on China.
Avoid panic-selling: Douglass calls for calm
12/03/2020  Share market speculation is almost always a bad idea, and panic-selling stocks on coronavirus fears is an example of just that, warns Magellan boss.
Coronavirus and the market: our take
11/03/2020  We offer three takeaways and advice on staying true to your goals.
Hits and misses aplenty in first half 2020 - Part 2
10/03/2020  Consumer stock Breville and listed property firm Charter Hall were among the highest gainers after delivering results, while Mayne Pharma and Seven West saw the sharpest falls.
Hits and misses aplenty in first half 2020 - Part 1
09/03/2020  The interim reporting season served up a lesson in why investors shouldn't rely too heavily on company forecasts, says Morningstar's Peter Warnes
The best diversifiers for your equity portfolio
05/03/2020  Christine Benz discusses how to protect your portfolio from a stock-market sell-off.
Green bonds offer another side to ESG investing
05/03/2020  Investors are largely unaware of the role fixed income can play in expressing their views on social, environmental and governance issues.
ETF investing for the new decade: 4 trends to watch
02/03/2020  In only a decade, the value of Australia's ETF market has risen by almost 2000 per cent.
The new medical device company to watch
28/02/2020  Spray-on skin maker Avita Medical has a chance of becoming the new standard in burns treatment, says Morningstar's Nicolette Quinn. 
Helping financial advisers help investors
27/02/2020  Financial advice can deliver value but we must do a better job of showing what that is and measuring it, says Morningstar chief executive Kunal Kapoor.
'ESG is about building a portfolio for outperformance'
26/02/2020  Morningstar CEO Kunal Kapoor explains the importance of ESG investing and why it's not simply a matter of avoiding guns, smokes and booze.
Volatility is here to stay - here's what to do
25/02/2020  Morningstar's director of personal finance Christine Benz explains how investors - young and old - should navigate how the coronavirus, the US election and frothy stock prices.
Why mining dividends are a flash in the pan
24/02/2020  A near-record dividend payout from BHP reflects high iron ore prices and miners flush with cash, but these conditions won’t continue long-term, says Morningstar’s Mat Hodge.
The case for emerging market debt
20/02/2020  Lazard Asset Management's Arif Joshi demystifies emerging market debt and explains why it can offer excess yields.
Telstra faces Vodafone-TPG tie-up
18/02/2020  Morningstar equity analyst Brian Han reckons the Vodafone-TPG is a 75pc chance of proceeding but says there's a risk of overestimating its effect on Telstra.
CBA result puts dividend fears to bed, NAB on track
14/02/2020  Despite a profit dip there are many positives for CBA, including growth in mortgages and deposits and a strong balance sheet, says Morningstar equity analyst Nathan Zaia.
Doubts over James Hardie's bullish outlook
14/02/2020  The building materials supplier's long-term North American market share forecast is too ambitious, says Grant Slade 
Could Coronavirus hit China's luxury boom?
12/02/2020  Morningstar analyst Jelena Sokolova looks at the potential impact of the coronavirus on the luxury goods sector.
4 healthcare stocks attractive on valuation and ESG risk
10/02/2020  Morningstar's Karen Andersen explains how environmental, social and governance issues affect Big Pharma and biotech companies.
Coal case: why Whitehaven is a Best Idea
07/02/2020  Lower costs, higher prices, and demand from Asia: key reasons why the miner's shares are going cheap, says Morningstar director of equity research Mathew Hodge.
Two of Morningstar's Best Ideas
04/02/2020  Morningstar's Adam Fleck explains how his team decides on which names to recommend and reveals a stock that is trading at a 30 per cent discount to its fair value estimate.
Behind Morningstar's Global Best Ideas list
03/02/2020  A margin of safety and high analyst conviction are just two of the criteria behind this monthly selection of stocks for your watchlist, says Morningstar's Adam Fleck.
Morningstar's tribute to Jack Bogle
29/01/2020  There has never been anyone who has given more to investors and taken less in return than Jack Bogle.
Kraft Heinz on the comeback trail
23/01/2020  As the faltering firm works toward a turnaround, patient investors should consider its undervalued shares.
3 foodie stock picks
21/01/2020  Sarasin's Jeneiv Shah looks at three stocks across the food chain, including one company trying to stop cows from burping.
Morningstar's predictions for 2020
16/01/2020  A contraction in housing starts; advances in electric vehicle technology; Trump re-election; a rate cut; and another tough year for banks - just some of what's expected.
3 European stock picks for 2020
14/01/2020  Unloved cable companies and property firms provide some of the best opportunities in Europe, says T. Rowe Price's Dean Tenerelli. 
Best of 2019: Why Iluka is bucking the mining company trend
09/01/2020  In May 2019, Morningstar's Mat Hodge explained why this rare earths company provides a different exposure to consumer materials, and has a clear path to revenue growth.
Best of 2019: how to pick stocks like Warren Buffett
08/01/2020  In this Best of 2019 video, Morningstar director of investor education Karen Wallace reveals how Warren Buffet benefited from sniffing out companies with competitive advantages.
Best of 2019: Coles, Woolies and shareholders face tough facts
07/01/2020  In 2019, we checked in with retail analyst Johannes Faul who explained how margin pressures affected supermarket giants Woolworths and Coles, and how the market reacted.
Best of 2019 videos: Warnes' downturn warning for investors
06/01/2020  In our look back at 2019, Morningstar head of equity research Peter Warnes identifies the performers of this earning season and issues a warning to investors of what action to take as uncertainty builds.
Morningstar year in review 2019
23/12/2019  Morningstar analysts look back at a year marked by a plunge in interest rates, shocks for the banking sector, China's vast appetite for iron ore, and the Coalition's upset election win.
What lies ahead for ASX, global markets in 2020 - Part 2
19/12/2019  Tension between big business, government and the Reserve Bank will spill into the new year and Australia's banks will likely remain under pressure.
What lies ahead for ASX, global markets in 2020 - Part 1
18/12/2019  The record stock market returns of 2019 are unlikely to be repeated next year or any time soon, says Morningstar’s Peter Warnes.
3 top picks: medical tech, bank and telco
16/12/2019  US President Trump’s trade war with China is a telco tailwind for Ericsson, says Fidelity’s Amit Lodha, who also likes medical technology firm Boston Scientific and Indian bank Kotak Mahindra.
Investors hunting for 'Switzerland'
13/12/2019  Investors are scrambling for safety as geopolitical tensions fuel the hunt for investable countries and ideas, says Fidelity’s global portfolio manager Amit Lodha.
Don’t abandon stocks amid rising market risk
11/12/2019  Low interest rates and a generally gloomy investment outlook magnifies the importance of picking quality, defensive companies for your portfolio, says Investors Mutual’s Hugh Giddy.
Where in the world can stock investors find value?
06/12/2019  US stocks hold only sparse opportunities for investors but parts of emerging Asia such as Korea and Japan are attractive, says Morningstar’s Daniel Needham.
Euro small caps among Bell’s top picks
05/12/2019  Global small- and mid-cap stocks still hold appeal for this manager, including Spanish airline booking and luxury goods companies Amadeus and Moncler.
Investors too bullish on Coles and Woolies, says Morningstar
04/12/2019  Australia’s biggest supermarkets are successfully defending their turf but high profit margins are ancient history, says Morningstar’s Johannes Faul.
Staying on budget over the holidays
03/12/2019  You might overspend because of “wealth effect”, or to keep up with the Joneses, but Morningstar’s Christine Benz has some ideas on how to not go over your budget.
Nine’s Stan holds high ground in streaming battle
29/11/2019  The local content strength of Nine-owned streaming video service Stan means it should prevail even as Disney+ launches locally alongside Netflix and other invaders, says Morningstar’s Brian Han.
Earnings bright side for Westpac
28/11/2019  Westpac has endured one of the most torrid weeks in its 200-year history but there's an upside, says Morningstar banking analyst Nathan Zaia.
How to find quality at a reasonable price
28/11/2019  Bell Asset Management's chief investment officer Ned Bell explains the principles of 'QARP' investing and singles out three companies that meet the criteria.
Taking the pulse at the Morningstar Individual Investor Conference
27/11/2019  Emma Rapaport taps conference goers for their thoughts on record low interest rates, stock opportunities, diversification and the merits of active management.
Dollar cost averaging doesn't work
25/11/2019  Investing a bit at a time is a bad idea, and buying the dip is an unnecessary risk, recent Morningstar research finds.
Banks, whistleblowers and the Hayne inquiry
19/11/2019  Investigative journalist and author Adele Ferguson discusses the banking royal commission outcome and whether shareholders should have a bigger role in policing their behaviour.
Paradigm shift is coming, says Warnes
14/11/2019  Unprecedented money printing and record low rates haven't worked and a 'paradigm shift' is afoot, argues Morningstar's Peter Warnes. 
Morningstar launches its first active ETF
12/11/2019  The head of Morningstar Investment Management Australia, Matt Wacher, reveals how the new International Shares Active ETF uses a quality- and value-led strategy to find opportunities in several global and emerging markets.
Understanding Morningstar Sustainability Ratings
12/11/2019  A Morningstar Sustainability Rating for funds helps investors make comparisons across industries and better understand and manage total ESG risk in their investments.
Should the home affect Age Pension eligibility?
11/11/2019  Whether the family home should be part of the Age Pension asset test continues to stir debate in Australia as do broader issues around retirement and superannuation, explains Graham Hand.
How to sort the winners from the also-rans
08/11/2019  Forget chasing the daily vagaries of the market and focus instead on stocks that will shine in their individual sectors, says Fidelity's Kate Howitt. 
Winds are shifting in US power generation market
06/11/2019  Natural gas and renewable energy, particularly solar and wind, will battle for top spot in the power generation stakes, says Morningstar's Charles Fishman.
There’s more to running an SMSF than paperwork and penalties
04/11/2019  Complexity has long been a bugbear of SMSF trustees, for whom the administrative burden is a necessary evil, but changes are afoot to help reduce the hassle, says Vanguard’s Robin Bowerman.
Investment opportunities abound in electric vehicles
31/10/2019  Morningstar equity analyst Seth Goldstein identifies his top picks in supply chain and ancillary industries.
Hamish Douglass: China is the opportunity of the next 20 years
30/10/2019  Magellan Financial Group's chief stockpicker on how to play the political risk of a runaway China, why 'tech' is a misleading word and why the future is bright for cloud computing.
Platinum's guide to playing politics
29/10/2019  Platinum Asset Management's Andrew Clifford on how to find overlooked opportunities and why demand for cars and computers will persist despite trade war tensions.
Why you should look on the bright side
25/10/2019  AMP Capital economist Shane Oliver explains why the sweep of history favours the optimists and why confidence is the key to successful investing. 
Why the Morningstar Individual Investor Conference matters
24/10/2019  Jamie Wickham explains the aims of the Morningstar Individual Investor Conference and identifies the issues that are front of mind for investors and self-funded retirees.
I don't agree with Trump on much, except US Treasuries
23/10/2019  The days of 8 per cent yields are gone but there are bond opportunities to be found in the US and Japan, says M&G's Jim Leaviss.
Where's the recession?
11/10/2019  RBC's Eric Lascelles helps us make sense of the mixed signals in the market today.
Weighing up the Latitude IPO
09/10/2019  High leverage and exposure to lower credit quality are among the reasons why Morningstar analyst Nathan Zaia recommends investors sidestep the Latitude Financial Group float. 
3 stocks with global ambitions
03/10/2019  JPMorgan Global Growth and Income Trust manager Tim Woodhouse picks a drinks firm with a celebrity twist, a European company with global reach and a US insurance giant
History doesn't repeat, but it rhymes
01/10/2019  Lower for longer interest rates, slowing economic growth and a paucity of yield opportunities are nothing new for this seasoned professional Australian stocks investor.